Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001662252-22-000017
Filing Date
2022-03-25
Accepted
2022-03-25 17:19:50
Documents
43
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A rgin10qa.htm   iXBRL 10-Q/A 267325
3 EX-31.1 ex31_1.htm EX-31.1 9254
4 EX-31.2 ex31_2.htm EX-31.2 9254
5 EX-32.1 ex32_1.htm EX-32.1 5148
6 GRAPHIC image_001.jpg GRAPHIC 8539
  Complete submission text file 0001662252-22-000017.txt   1625764

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE rgin-20211231.xsd EX-101.SCH 16963
8 XBRL CALCULATION FILE rgin-20211231_cal.xml EX-101.CAL 22423
9 XBRL DEFINITION FILE rgin-20211231_def.xml EX-101.DEF 37463
10 XBRL LABEL FILE rgin-20211231_lab.xml EX-101.LAB 132426
11 XBRL PRESENTATION FILE rgin-20211231_pre.xml EX-101.PRE 102605
38 EXTRACTED XBRL INSTANCE DOCUMENT rgin10qa_htm.xml XML 121720
Mailing Address 10 HIGH COURT LITTLE FALLS NJ 07424
Business Address 10 HIGH COURT LITTLE FALLS NJ 07424 (973) 557-8914
Regenicin, Inc. (Filer) CIK: 0001412659 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 333-146834 | Film No.: 22772444
SIC: 3841 Surgical & Medical Instruments & Apparatus